These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30793706)

  • 21. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    Marin-Alejandre BA; Abete I; Cantero I; Riezu-Boj JI; Milagro FI; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martínez JA; Zulet MA
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures.
    Balakrishnan M; El-Serag HB; Nguyen T; Hilal J; Kanwal F; Thrift AP
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1965-1967. PubMed ID: 28642206
    [No Abstract]   [Full Text] [Related]  

  • 24. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study.
    Wang Q; Zheng D; Liu J; Fang L; Li Q
    Lipids Health Dis; 2018 Dec; 17(1):284. PubMed ID: 30545385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease.
    Eslam M; George J
    Hepatol Int; 2019 Nov; 13(6):662-664. PubMed ID: 31586267
    [No Abstract]   [Full Text] [Related]  

  • 26. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
    Fracanzani AL; Pisano G; Consonni D; Tiraboschi S; Baragetti A; Bertelli C; Norata GD; Dongiovanni P; Valenti L; Grigore L; Tonella T; Catapano A; Fargion S
    PLoS One; 2016; 11(9):e0162473. PubMed ID: 27627804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and inflammation.
    Karczewski J; Śledzińska E; Baturo A; Jończyk I; Maleszko A; Samborski P; Begier-Krasińska B; Dobrowolska A
    Eur Cytokine Netw; 2018 Sep; 29(3):83-94. PubMed ID: 30547890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
    Chang EJ; Yi DY; Yang HR
    J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice.
    Singh DP; Khare P; Zhu J; Kondepudi KK; Singh J; Baboota RK; Boparai RK; Khardori R; Chopra K; Bishnoi M
    Int J Obes (Lond); 2016 Mar; 40(3):487-96. PubMed ID: 26395746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice.
    Zhang X; Song Y; Ding Y; Wang W; Liao L; Zhong J; Sun P; Lei F; Zhang Y; Xie W
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30060618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
    Ybarra J; Fernández S; Sánchez-Hernández J; Romeo JH; Ballesta-Lopez C; Guell J; Mearin F
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):654-60. PubMed ID: 24667349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sonographically measured suprailiac adipose tissue is a useful predictor of non-alcoholic fatty liver disease in obese children and adolescents.
    Schlieske C; Denzer C; Wabitsch M; Oeztuerk S; Mason RA; Thiere D; Kratzer W
    Pediatr Obes; 2015 Aug; 10(4):260-6. PubMed ID: 25251446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study.
    Kim BJ; Cheong ES; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(3):619-626.e1. PubMed ID: 27206950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features.
    Valentini D; Alisi A; di Camillo C; Sartorelli MR; Crudele A; Bartuli A; Nobili V; Villani A
    J Pediatr; 2017 Oct; 189():92-97.e1. PubMed ID: 28662945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
    Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
    Yang Z; Zhu MZ; Zhang YB; Wen BB; An HM; Ou XC; Xiong YF; Lin HY; Liu ZH; Huang JA
    Phytother Res; 2019 Apr; 33(4):1019-1026. PubMed ID: 30746789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity.
    Mulder P; Morrison MC; Wielinga PY; van Duyvenvoorde W; Kooistra T; Kleemann R
    Int J Obes (Lond); 2016 Apr; 40(4):675-84. PubMed ID: 26499443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance.
    Nishio N; Isobe K
    Sci Rep; 2015 Aug; 5():13519. PubMed ID: 26316333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.